Arena Pharmaceuticals

17.02.2023 • News

Aristea Halts Clinical Trial, Dissolves Company

Safety findings in Phase 2 clinical trials have forced Aristea Therapeutics to stop developing its lead candidate RIST4721 for treating serious immune-mediated inflammatory diseases. As a consequence, Aristea’s management has decided to dissolve the company.

07.01.2013 • News

Vivus Obesity Pill Prescriptions Jump 68%

28.06.2012 • News

FDA OKs First Obesity Drug in 13 years

Top-Feature

Ecocool GmbH

Transport Logistic: Ecocool Presents Packaging Solutions for Pharmaceutical Transports

IMCD Deutschland GmbH

Fostering Innovation and Collaboration

Evonik Industries AG

Maximize the Potential of Spent Hydroprocessing Catalysts

Free Virtual Event

Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.